PR Stories

In Memoriam: Sharon B. Murphy, MD (1943–2023)

December 15, 2023

We share with great sadness that the inaugural director of the Greehey Children's Cancer Research Institute has passed.  Below is the obituary originally published in the American Society of Pediatric Hematology/Oncology on November 18, 2023.  She will always be remembered by those of us who were fortunate enough to work with her. It is an [...]

OpenAccessGovernment.org: Current and future therapy for BRAF-mutant pediatric glioma

November 20, 2023

Professor Peter J. Houghton from the Greehey Children’s Cancer Research Institute discusses new approaches to pediatric cancer treatment, specifically for BRAF-mutant pediatric glioma. Low-grade glioma (LGG) is the most frequently diagnosed brain tumor in children, and although five and ten-year survival is quite high, this does not reveal the toxicity of current therapies. Conventional treatment includes intensive chemo-radiation [...]

UT Health San Antonio gears up to fight childhood cancer, thanks to Hyundai Hope on Wheels® grants

September 26, 2023

Posted on September 26, 2023 at 10:40 am.Shared by Eileen Teves Contacts: Monica Taylor, 210-450-8970, taylorm1@uthscsa.edu, Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO – Children with cancer were joined by their families as they dipped their hands in finger paint and left their mark on a new Hyundai SUV at The University of Texas Health Science [...]

Open Access Government: Developing novel therapies for childhood cancers (Houghton)

September 19, 2023

Dr Peter J Houghton from Greehey Children’s Cancer Research Institute discusses the obstacles in developing new treatments for childhood cancers and new approaches in preclinical testing. In my previous article for Open Access Government, I focused on the challenges of developing novel therapies for children with glioma, the most prevalent brain cancer in children. Here, [...]

Texas Public Radio: “Fighting childhood cancer in San Antonio” (Aune)

September 8, 2023

September is Childhood Cancer Awareness Month, a time to raise awareness of this devastating disease and to support the children and families who are affected by it. Childhood cancer is the leading cause of death by disease for children under the age of 14. Each year, about 15,000 children in the United States are diagnosed [...]

Dr. Gupta to Present at Cold Spring Harbor Laboratory Meeting on Eukaryotic mRNA Processing, August 22-26, 2023

August 2, 2023

Click on image below for full agenda _________________________________________________________ Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to understanding its causes, and accelerate the translation of knowledge into novel therapies. Greehey CCRI strives to have a national and global impact on [...]

Panneerdoss Subbarayalu, PhD, to receive NIH, NCI R21 Grant, “Targeting the RNA Modifying Enzyme ALKBH5 in Medulloblastoma

June 5, 2023

Project Title: Targeting the RNA modifying enzyme ALKBH5 in Medulloblastoma Principal Investigator: Panneerdoss Subbarayalu Co-Investigators: Manjeet Rao, PhD, Andrew Brenner, MD, PhD., Peter Houghton, PhD. Funding Agency: National Institutes of Health, NATIONAL CANCER INSTITUTE Medulloblastoma is the most common malignant brain cancer in children. Despite the progress in treating medulloblastoma, the 5-year survival rate for high-risk [...]

Paulomi Modi (Ignatius Lab) Recognized as 2023 Presidential Ambassador Scholar

May 8, 2023

Ambassadors from left to right: Gina Baxter (SHP), Avani Ved (SON), Paulomi Modi (GSBS), Alejandra Garcia (LSOM) and Tyler Childs (SOD) Paulomi Modi is a second-year PhD student in the Integrated Biomedical Sciences program at the Graduate School of Biomedical Sciences.  At 17, Modi moved to the United States on her own and later graduated [...]

Precision Oncology News: Lantern Pharma Preparing IND for Synthetic Lethality Program With FDA Feedback

January 18, 2023

      Jan 17, 2023 | staff reporter NEW YORK – Lantern Pharma on Tuesday said it received feedback from the US Food and Drug Administration that it will use to submit an investigational new drug application for LP-184. The company further plans to begin studying the drug in a Phase I trial of [...]

Luiz Penalva, PhD to Receive Mike Hogg Fund Award

December 15, 2022

Luiz O.F. Penalva, PhD to receive an award from the Mike Hogg Fund in support of his study, “Preventing Senescence Scape to Overcome Tumor Recurrence in Glioblastoma.” Learn more about Dr. Penalva's research